NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/18/2026
Back to search
Official data from USPTO
HUMIRA COMPLETE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HUMIRA COMPLETE
ST13
US500000088329274Class
41, 42, 44
Filing
88329274
Registration
6020255
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
06/19/2026
Trademark type
Word
Nice classes
41, 42, 44
Filing date
03/07/2019
Registration date
03/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2026
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2013
First use in commerce
01/01/2013
Drawing code
4
Owner type
03
Owner location
Hamilton, BM
Examiner
BULLOFF, TOBY ELLEN
Current location
Historical data usage
Holders and representatives
Holders
AbbVie Biotechnology Ltd
Representatives
Sonali S. Srivastava ABBVIE INC.
Technical classification
Nice Classes
Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Providing a website featuring nondownloadable publications in the nature of brochuresarticles and newsletters in the field of health; Educational servicestraining in the field of immunologyauto-immune diseasesdermatologyrheumatologygastroenterology and treatments thereof
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunologyauto-immune diseasesdermatologyrheumatologygastroenterology and treatments thereof via the internetdigital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; Providing scientific information in the field of epidemiologydisease backgroundreal world evidencepharmaceuticals and clinical trials; providing scientific information in the field of immunologyauto-immune diseasesdermatologyrheumatologygastroenterology and treatments thereof via the internetdigital media and data banks; provision of scientific information concerning epidemiological study resultsreal world evidenceclinical study results and clinical study data by means of interactive web sites; providing an interactive web site featuring scientific information on clinical studies and clinical study results
Class 44
Providing health information
Publications
History of USPTO decisions and trademark events.
20 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/18/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/23/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/24/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/20/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/19/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/04/2020
IUAF
USE AMENDMENT FILED
01/15/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/15/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/16/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2019
PUBO
PUBLISHED FOR OPPOSITION
05/21/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2019
DOCK
ASSIGNED TO EXAMINER
03/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2019
NWAP
NEW APPLICATION ENTERED
03/11/2019
Continuous trademark protection
Get notified about every new filing that threatens HUMIRA COMPLETE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.